M1 Kliniken AG(DE:M12)
€19.48+0.04 (+0.21%)
DE:M12
M1 Kliniken AG financials statements
€19.48
At close:+0.04 (+0.21%)
Want to see DE:M12 full AI Analyst Report?
M1 Kliniken AG (M12) Ratios
14 Followers
M1 Kliniken AG Ratios
DE:M12's free cash flow for Q2 2026 was €8.26M. For the 2026 fiscal year, DE:M12's free cash flow was decreased by €-171.55K and operating cash flow was €8.43M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.82 | 1.91 | 1.90 | 2.86 | 2.54 |
| Quick Ratio | 1.82 | 1.08 | 1.12 | 2.13 | 1.73 |
| Cash Ratio | 1.19 | 0.49 | 0.38 | 0.94 | 0.87 |
| Solvency Ratio | 0.69 | 0.40 | 0.22 | 0.19 | 0.25 |
| Operating Cash Flow Ratio | 1.20 | 0.70 | 0.13 | 0.56 | 0.36 |
| Short-Term Operating Cash Flow Coverage | 7.29 | 2.85 | 2.22 | 8.84 | 1.08 |
| Net Current Asset Value | € 50.06M | € 29.90M | € 40.86M | € 53.33M | € 51.99M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.06 | 0.08 | 0.10 | 0.16 |
| Debt-to-Equity Ratio | 0.09 | 0.10 | 0.15 | 0.21 | 0.33 |
| Debt-to-Capital Ratio | 0.08 | 0.09 | 0.13 | 0.17 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.02 | 0.03 | 0.04 |
| Financial Leverage Ratio | 1.58 | 1.77 | 1.88 | 2.06 | 2.08 |
| Debt Service Coverage Ratio | 4.52 | 1.97 | 3.49 | 4.02 | 1.05 |
| Interest Coverage Ratio | 23.87 | 13.89 | 11.65 | 11.29 | 13.24 |
| Debt to Market Cap | 0.01 | 0.03 | 0.03 | 0.03 | 0.14 |
| Interest Debt Per Share | 0.64 | 0.67 | 0.96 | 1.12 | 1.71 |
| Net Debt to EBITDA | -0.68 | -0.33 | -0.24 | -0.96 | -0.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 13.02% | 18.75% | 10.27% | 7.61% | 8.28% |
| EBIT Margin | 9.77% | 8.32% | 5.21% | 3.58% | 4.49% |
| EBITDA Margin | 11.11% | 9.86% | 6.89% | 5.63% | 6.29% |
| Operating Profit Margin | 10.09% | 7.89% | 4.96% | 3.28% | 3.86% |
| Pretax Profit Margin | 9.35% | 7.75% | 5.20% | 3.59% | 4.58% |
| Net Profit Margin | 6.08% | 4.72% | 3.25% | 1.51% | 2.83% |
| Continuous Operations Profit Margin | 6.62% | 5.25% | 3.69% | 2.48% | 3.46% |
| Net Income Per EBT | 64.98% | 60.91% | 62.47% | 42.19% | 61.74% |
| EBT Per EBIT | 92.71% | 98.30% | 104.75% | 109.48% | 118.86% |
| Return on Assets (ROA) | 11.69% | 8.53% | 4.82% | 2.19% | 4.50% |
| Return on Equity (ROE) | 18.45% | 15.10% | 9.07% | 4.52% | 9.37% |
| Return on Capital Employed (ROCE) | 23.31% | 18.56% | 10.15% | 5.86% | 7.84% |
| Return on Invested Capital (ROIC) | 15.76% | 11.46% | 6.91% | 3.91% | 5.29% |
| Return on Tangible Assets | 22.33% | 15.95% | 8.18% | 4.21% | 8.61% |
| Earnings Yield | 6.28% | 5.20% | 4.80% | 2.60% | 6.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 41.71 | 19.25 | 11.29 | 12.66 | 19.29 |
| Payables Turnover | 37.56 | 21.25 | 8.54 | 13.71 | 22.46 |
| Inventory Turnover | 9.98 | 7.63 | 6.23 | 9.55 | 8.20 |
| Fixed Asset Turnover | 38.70 | 26.27 | 22.93 | 16.61 | 20.61 |
| Asset Turnover | 1.92 | 1.81 | 1.49 | 1.45 | 1.59 |
| Working Capital Turnover Ratio | 7.48 | 7.36 | 5.18 | 4.18 | 4.80 |
| Cash Conversion Cycle | 35.62 | 49.64 | 48.11 | 40.41 | 47.20 |
| Days of Sales Outstanding | 8.75 | 18.96 | 32.33 | 28.82 | 18.92 |
| Days of Inventory Outstanding | 36.59 | 47.86 | 58.54 | 38.20 | 44.53 |
| Days of Payables Outstanding | 9.72 | 17.18 | 42.76 | 26.62 | 16.25 |
| Operating Cycle | 45.34 | 66.82 | 90.88 | 67.03 | 63.45 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.05 | 1.65 | 0.41 | 1.15 | 0.84 |
| Free Cash Flow Per Share | 2.04 | 1.59 | 0.36 | 1.05 | 0.77 |
| Dividend Paid and CapEx Coverage Ratio | 4.03 | 2.96 | 2.61 | 5.85 | 5.23 |
| Capital Expenditure Coverage Ratio | 344.29 | 30.69 | 7.74 | 11.86 | 11.72 |
| Operating Cash Flow Coverage Ratio | 3.70 | 2.93 | 0.46 | 1.07 | 0.51 |
| Operating Cash Flow to Sales Ratio | 0.10 | 0.09 | 0.02 | 0.07 | 0.05 |
| Free Cash Flow Yield | 10.73% | 9.59% | 3.17% | 11.60% | 10.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.97 | 19.30 | 20.85 | 38.43 | 15.65 |
| Price-to-Sales (P/S) Ratio | 0.97 | 0.91 | 0.68 | 0.58 | 0.44 |
| Price-to-Book (P/B) Ratio | 2.94 | 2.90 | 1.89 | 1.74 | 1.47 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 9.32 | 10.42 | 31.50 | 8.62 | 9.73 |
| Price-to-Operating Cash Flow Ratio | 9.29 | 10.08 | 27.43 | 7.89 | 8.90 |
| Price-to-Earnings Growth (PEG) Ratio | 0.42 | 0.33 | 0.17 | -0.77 | 0.53 |
| Enterprise Value Multiple | 8.03 | 8.88 | 9.58 | 9.36 | 6.70 |
| Enterprise Value | 325.04M | 297.00M | 208.87M | 150.46M | 132.42M |
| EV to EBITDA | 8.03 | 8.88 | 9.58 | 9.36 | 6.70 |
| EV to Sales | 0.89 | 0.88 | 0.66 | 0.53 | 0.42 |
| EV to Free Cash Flow | 8.59 | 10.05 | 30.72 | 7.82 | 9.25 |
| EV to Operating Cash Flow | 8.57 | 9.72 | 26.75 | 7.16 | 8.46 |
| Tangible Book Value Per Share | 3.22 | 2.52 | 2.92 | 2.65 | 2.43 |
| Shareholders’ Equity Per Share | 6.46 | 5.72 | 5.92 | 5.22 | 5.11 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.29 | 0.32 | 0.29 | 0.31 | 0.25 |
| Revenue Per Share | 19.63 | 18.28 | 16.54 | 15.58 | 16.93 |
| Net Income Per Share | 1.19 | 0.86 | 0.54 | 0.24 | 0.48 |
| Tax Burden | 0.65 | 0.61 | 0.62 | 0.42 | 0.62 |
| Interest Burden | 0.96 | 0.93 | 1.00 | 1.00 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.57 | 1.72 | 0.76 | 4.87 | 1.76 |
Currency in EUR
